The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer
2009

New Animal Model for Studying Liver Metastases in Colon Cancer

Sample size: 39 publication Evidence: moderate

Author Information

Author(s): Andreas Thalheimer, Christoph Otto, Marco Bueter, Bertram Illert, Stefan Gattenlohner, Martin Gasser, Detlef Meyer, Martin Fein, Christoph T Germer, Ana M Waaga-Gasser

Primary Institution: University of Wuerzburg Hospital

Hypothesis

Can intraportal injection of colon carcinoma cell lines in immunoincompetent mice create a reliable model for studying hepatic metastases and tumor cell dissemination?

Conclusion

The intraportal injection model effectively induces both hepatic metastases and tumor cell dissemination in bone marrow, making it a valuable tool for cancer research.

Supporting Evidence

  • Injection of 1 × 106 cells resulted in hepatic metastases in up to 89% of animals.
  • 63% of animals with hepatic metastases showed tumor cell dissemination in bone marrow.
  • The model allows for the study of minimal residual disease in a controlled environment.

Takeaway

Researchers injected cancer cells into mice to see if they could create liver tumors and spread cancer cells to the bone marrow, which they successfully did.

Methodology

Immunoincompetent nude mice were injected intraportally with varying numbers of colon carcinoma cells, and the occurrence of metastases and tumor cell dissemination was assessed.

Limitations

The model showed high perioperative mortality with larger cell counts, limiting the number of cells that can be injected.

Participant Demographics

Female Balb/c nu/nu mice, aged 6 to 10 weeks.

Digital Object Identifier (DOI)

10.1186/1471-2407-9-29

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication